REGENXBIO to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 10, 2017 20:06 pm UTC| Business
ROCKVILLE, Md., May 10, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
REGENXBIO to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 10, 2017 20:06 pm UTC| Business
ROCKVILLE, Md., May 10, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
Stewardship Financial Corporation Announces Earnings For The First Quarter of 2017
May 10, 2017 20:06 pm UTC| Business
MIDLAND PARK, N.J., May 10, 2017 -- Stewardship Financial Corporation (NASDAQ:SSFN), parent company of Atlantic Stewardship Bank, announced net income for the three months ended March 31, 2017 of $991,000, or $0.16 per...
Stewardship Financial Corporation Announces Earnings For The First Quarter of 2017
May 10, 2017 20:06 pm UTC| Business
MIDLAND PARK, N.J., May 10, 2017 -- Stewardship Financial Corporation (NASDAQ:SSFN), parent company of Atlantic Stewardship Bank, announced net income for the three months ended March 31, 2017 of $991,000, or $0.16 per...
MaxPoint Interactive Announces First Quarter 2017 Earnings Results
May 10, 2017 20:06 pm UTC| Business
GAAP Revenue of $27.9 million and Non-GAAP Revenue ex-TAC1 of $19.1 million.GAAP Net Loss improves by $1.5 million and Non-GAAP Adjusted EBITDA1 improves by $2.3 million for the first quarter 2017 versus 2016.RALEIGH,...
MaxPoint Interactive Announces First Quarter 2017 Earnings Results
May 10, 2017 20:06 pm UTC| Business
GAAP Revenue of $27.9 million and Non-GAAP Revenue ex-TAC1 of $19.1 million.GAAP Net Loss improves by $1.5 million and Non-GAAP Adjusted EBITDA1 improves by $2.3 million for the first quarter 2017 versus 2016.RALEIGH,...
Nabriva Therapeutics Reports First Quarter 2017 Financial Results
May 10, 2017 20:06 pm UTC| Business
VIENNA, Austria and KING OF PRUSSIA, Pa., May 10, 2017 -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat...